Neurogene Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$31.45

-0.83 (-2.57%)

As of Jun 30, 10:20 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -20.1% upside

Low Target $17.03

Average Target $25.14

High Target $37.02

Current Price $31.45

Current
$31.45

Target
$25.14

$17.03 $25.14 avg $37.02

Scenario Analysis

Bear Case

$17.03

-45.9%

Low target

Base Case

$25.14

-20.1%

Avg target

Bull Case

$37.02

+17.7%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$37.27

-15.6% from high

52-Week Low

$14.65

+114.7% from low

Target vs 52W High

$25.14

-32.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%